No abstract available
MeSH terms
-
Adalimumab / therapeutic use
-
Antirheumatic Agents* / adverse effects
-
Axial Spondyloarthritis*
-
Humans
-
Spondylarthritis* / diagnosis
-
Spondylarthritis* / drug therapy
-
Spondylitis, Ankylosing* / diagnosis
-
Spondylitis, Ankylosing* / drug therapy
-
Tumor Necrosis Factor Inhibitors / adverse effects
-
Tumor Necrosis Factor-alpha
Substances
-
Tumor Necrosis Factor Inhibitors
-
Antirheumatic Agents
-
Adalimumab
-
Tumor Necrosis Factor-alpha